Tuberculosis in Europe: a problem of drug resistance or much more?

References

• Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in Western Europe. Bull. World Health Organ.71, 297–306 (1993).
   PubMed Web of Science ®Google Scholar
• Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med.328, 521–526 (1993).
   PubMed Web of Science ®Google Scholar
• Willcox PA. Drug-resistant tuberculosis: worldwide trends, problems specific to Eastern Europe and other hotspots, and the threat to developing countries. Curr. Opin. Pulm. Med.7, 148–153 (2001).
   PubMedGoogle Scholar
• Dye C. Global epidemiology of tuberculosis. Lancet367, 938–940 (2006).
   PubMed Web of Science ®Google Scholar
• Wright A, Zignol M, Van Deun A et al. Epidemiology of antituberculosis drug resistance 2002–2007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet373, 1861–1873 (2009).
   PubMed Web of Science ®Google Scholar
• Drobniewski FA, Balanova YM, Ruddy MC et al. Tuberculosis, HIV seroprevalence and intravenous drug use in prisioners. Eur. Respir. J.26, 298–304 (2005).
   PubMedGoogle Scholar
• Falzon D, Aït-Belghit F. What is tuberculosis surveillance in the European Union telling us? CID44, 1261–1267 (2007).
   PubMedGoogle Scholar
• Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int. J. Tuberc. Lung Dis.11, 353–354 (2007).
   PubMedGoogle Scholar
• Dubos R, Dubos J. The White Plague: Tuberculosis, Man, and Society. Rutgers University Press, NJ, USA (1987).
   Google Scholar
• Chretien J. Tuberculosis. The Illustrated History of a Disease. Volume 1. The Union, Paris, France (1998).
   Google Scholar
• Rieder HL, Cauthen GM, Comstock GW, Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol. Rev.11, 79–98 (1989).
   PubMedGoogle Scholar
• Davies R, Tocque K, Bellis M, Rimmington T, Davies P. Historical declines in tuberculosis in England and Wales: improving social conditions or natural selection? Int. J. Tuberc. Lung Dis.3, 1051–1054 (1999).
   PubMed Web of Science ®Google Scholar
• Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc. Sci. Med.68, 2240–2246 (2009).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (CDC). Tuberculosis, final data: United States 1986. Morb. Mortal. Wkly Rep.36, 817–820 (1988).
   PubMedGoogle Scholar
• Raviglione M, Uplekar M. WHO’s new Stop TB strategy. Lancet367, 952–955 (2006).
   PubMed Web of Science ®Google Scholar
• Velasco M, Castilla V, Cervero M et al.; for the COMESEM cohort. The changing pattern of tuberculosis and HIV co-infection in immigrants and Spaniards in the last 20 years. HIV Med.9, 227–233 (2008).
   PubMedGoogle Scholar
• Leimane V, Leimans J. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes. Eur. Surveill.11, 29–33 (2006).
   PubMedGoogle Scholar
• Broekmans JF, Migliori GB, Rieder HL et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur. Respir. J.19, 765–775 (2002).
   PubMed Web of Science ®Google Scholar
• Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int. J. Tuberc. Lung Dis.8, 751–757 (2003).
   Google Scholar
• Zipperer M. Tackling tuberculosis in Latvia. PLoS Med.2(5), e122 (2005).
   Google Scholar
• Vynnycky E, Borgdoff MW, Leung CC, Tam CM, Fine PE. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol. Infect.136, 943–952 (2008).
   PubMedGoogle Scholar
• Tocque K, Bellis MA, Tam CM et al. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am. J. Respir. Crit. Care Med.158, 484–488 (1998).
   PubMedGoogle Scholar
• Davies PDO, Woo J, Moore-Gillon J. Tuberculosis in the elderly. In: Tuberculosis. A Comprehensive International Approach (3rd Edition). Raviglione MC (Ed.). Informa Health Care, London, UK (2006).
   Google Scholar
• Davies PDO. TB in the elderly in industrialised countries. Int. J. Tuberc. Lung Dis.11, 1157–1159 (2007).
   PubMedGoogle Scholar
• Pešut DP, Gledović ZB, Grgurević AD, Nagorni-Obradović LM, Adžić TN. Tuberculosis incidence in elderly in Serbia: key trends in socioeconomic transition. Croat. Med. J.49, 807–812 (2008).
   PubMedGoogle Scholar
• Pérez-Gusmán C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? Chest116, 961–967 (1999).
   PubMedGoogle Scholar
• Haanaes OC, Bergmann A. Tuberculosis emerging in patients treated with corticosteroids. Eur. J. Resp. Dis.64, 229–237 (1983).
   PubMedGoogle Scholar
• Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N. Engl. J. Med.312, 1483–1487 (1985).
   PubMed Web of Science ®Google Scholar
• Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest114, 1244–1252 (1998).
   PubMed Web of Science ®Google Scholar
• Sime PJ, Chilvers ER, Leitch AG. Miliary tuberculosis in Edinburgh – a comparison between 1984–1992 and 1954–1967. Respir. Med.88, 609–611 (1994).
   PubMedGoogle Scholar
• Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect. Dis.5, 415–430 (2005).
   PubMed Web of Science ®Google Scholar
• Rieder HL, Kelly GD, Bloch AB, Cauthen GM, Snider DEJ. Tuberculosis diagnosed at death in the United States. Chest100, 678–811 (1991).
   PubMed Web of Science ®Google Scholar
• MacGee W. The frequency of unsuspected tuberculosis found post-mortem in a geriatric population. Z. Gerontol.22, 311–314 (1989).
   PubMedGoogle Scholar
• Humphries MJ, Byfield SP, Darbyshire JH et al. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br. J. Dis. Chest78, 149–158 (1984).
   PubMedGoogle Scholar
• Martineau A, Lowey H, Tocque K, Davies POD. Case–fatality from tuberculosis by age and site in England and Wales. Int. J. Tuberc. Lung Dis.8, 732–742 (2004).
   Google Scholar
• Ijaz K, Dillaha JA, Yang Z, Cave MD, Bates JH. Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. J. Am. Geriatr. Soc.50, 1213–1218 (2002).
   PubMedGoogle Scholar
• Nisar M, Williams CS, Ashby D, Davies PD. Tuberculin testing in residential homes for the elderly. Thorax48, 1257–1260 (1993).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (CDC). Prevention and control of tuberculosis in facilities providing long-term care to the elderly recommendations of the advisory committee for elimination of tuberculosis. MMWR Recomm. Rep.39, 7–20 (1990).
   PubMedGoogle Scholar
• Gisselbrecht M. La tuberculose chez les personnes âgées en institution. Rev. Mal. Respir.20, 912–913 (2003).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Multidrug-resistant tuberculosis outbreak on an HIV ward – Madrid, Spain, 1991–1995. MMWR Morb. Mortal. Wkly Rep.45, 330–333 (1996).
   PubMedGoogle Scholar
• Moro ML, Gori A, Errante I et al. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. AIDS18, 1095–1102 (1998).
   Google Scholar
• Hannan MM, Peres H, Maltez F et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital, 1995–1996. J. Hosp. Infect.47, 91–97 (2001).
   PubMedGoogle Scholar
• Castilla J, Gutiérrez A, Guerra L et al. Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and implications for control. AIDS11, 1583–1588 (1997).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Morb. Mortal. Wkly Rep.58, 1–207 (2009).
   PubMedGoogle Scholar
• Girardi E, Antonucci G, Vanacore P et al. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur. Respir. J.24, 11–17 (2004).
   PubMedGoogle Scholar
• Jones JL, Hanson DL, Dworkin MS, DeCock KM. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. Int. J. Tuberc. Lung Dis.14, 1985–1991 (2000).
   Google Scholar
• Girardi E, Antonucci G, Vanacore P et al. Impact of combination therapy on the risk of tuberculosis among persons with HIV infection. AIDS14, 1985–1991 (2000).
   PubMed Web of Science ®Google Scholar
• de Colombani P, Banatvala N, Zaleskis R, Maher D. European framework to decrease the burden of TB/HIV. Eur. Respir. J.24, 493–501 (2004).
   PubMedGoogle Scholar
• Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax62, 667–671 (2007).
   PubMed Web of Science ®Google Scholar
• van der Werf M J, Yegorova OB, Chentsova N et al. Tuberculosis–HIV co-infection in Kiev City, Ukraine. Emerg. Infect. Dis.5, 766–768 (2006).
   Google Scholar
• Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch. Intern. Med.139, 337–339 (1979).
   PubMedGoogle Scholar
• Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am. Rev. Respir. Dis.136, 1188–1192 (1987).
   PubMedGoogle Scholar
• Braum MM, Truman BI, Maguire B et al. Increasing incidence of tuberculosis in a prison inmate population. JAMA261, 393–397 (1989).
   PubMedGoogle Scholar
• Zolopa AR, Hahn JA, Gorter R et al. HIV and tuberculosis infection in San Francisco’s homeless adults: prevalence and risk factors in a representative sample. JAMA272, 455–461 (1994).
   PubMed Web of Science ®Google Scholar
• Martin V, Caylà JA, Bolea A, Castilla J. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int. J. Tuberc. Lung Dis.4, 41–46 (2000).
   PubMed Web of Science ®Google Scholar
• Story A, Bothamley G, Hayward A. Crack cocaine and infectious tuberculosis. Emerg. Infect. Dis.9, 1466–1469 (2008).
   Google Scholar
• Aerts A, Hauer B, Wanlin M, Veen J. Tuberculosis and tuberculosis control in European prisons. Int. J. Tuberc. Lung Dis.11, 1215–1223 (2006).
   Google Scholar
• Fleming MF, Krupitsky E, Tsoy M et al. Tuberculosis knowledge, perceived risk and risk behaviors among homeless adults: effect of ethnicity and injection drug use. J. Community Health29, 483–497 (2004).
   PubMedGoogle Scholar
• Szabo G. Alcohol’s contribution to compromised immunity. Alcohol Health Res. World21, 30–41 (1997).
   PubMedGoogle Scholar
• Lonnroth K, Raviglione M. Global tuberculosis epidemiology – prospects for control. Semin. Respir. Crit. Care Med.29, 481–491 (2008).
   PubMed Web of Science ®Google Scholar
• Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health8, 289 (2008).
   PubMed Web of Science ®Google Scholar
• Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int. J. Tuberc. Lung Dis.10, 857–863 (2006).
   PubMed Web of Science ®Google Scholar
• Gelmanova IY, Keshavjee S, Golubchikova VT et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull. World Health Org.85, 703–711 (2007).
   PubMedGoogle Scholar
• van der Werf MJ, Chechulin Y, Yegorova OB et al. Health care seeking behaviour for tuberculosis symptoms in Kiev City, Ukraine. Int. J. Tuberc. Lung Dis.10, 390–395 (2006).
   PubMedGoogle Scholar
• Zaridze D, Brennan P, Boreham J et al. Alcohol and cause-specific mortality in Russia: a retrospective case–control study of 48 557 adult deaths. Lancet27, 2201–2214 (2009).
   Google Scholar
• Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg. Infect. Dis.8, 679–684 (2002).
   PubMed Web of Science ®Google Scholar
• Farah MG, Meyer HE, Selmer R, Heldal E, Bjune G. Long-term risk of tuberculosis among immigrants in Norway. Int. J. Epidemiol.34, 1005–1011 (2005).
   PubMedGoogle Scholar
• Kik SV, Olthof SPJ, de Vries JT et al. Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC Public Health9, 283 (2009).
   PubMedGoogle Scholar
• Farge D, Porcher R, Antoun F et al.; members of the TB-INFO Association. Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int. J. Tuberc. Lung Dis.11, 992–998 (2007).
   PubMedGoogle Scholar
• Bothamley GH, Ditiu L, Migliori GB, Lange C; TBNET contributors. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur. Respir. J.32, 1023–1030 (2008).
   PubMedGoogle Scholar
• Coker R, Bell A, Pitman R et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur. Respir. J.27, 801–807 (2006).
   PubMed Web of Science ®Google Scholar
• Hargreaves S, Carballo M, Friedland JS. Screening migrants for tuberculosis: where next? Lancet Infect. Dis.9, 139–140 (2009).
   PubMedGoogle Scholar
• Carvalho ACC, Saleri N, El-Hamad I et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol. Infect.133, 179–185 (2005).
   PubMedGoogle Scholar
• Bodenmann P, Vaucher P, Wolff H et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive explanatory study. BMC Infect. Dis.9, 34 (2009).
   PubMedGoogle Scholar
• Lillebaek T, Andersen AB, Bauer J et al. Risk of Mycobacterium tuberculoisis transmission in a low-incidence country due to immigration from high-incidence areas. J. Clin. Microbiol.39, 855–861 (2001).
   PubMed Web of Science ®Google Scholar
• Matteelli A, Gori A, Pinsi G et al. Clustering of tuberculosis among Senegalese immigrants in Italy. Int. J. Tuberc. Lung Dis.7, 967–972 (2003).
   PubMedGoogle Scholar
• Diel R, Rüsch-Gerdes S, Niemann S. Molecular epidemiology of tuberculosis among immigrants in Hamburg, Germany. J. Clin. Microbiol.42, 2952–2960 (2004).
   PubMedGoogle Scholar
• Del Amo J, Petruckevitch A, Philips AN et al. Risk factors for tuberculosis in patients with AIDS in London: a case-control study. Int. J. Tuberc. Lung Dis.3, 12–17 (1999).
   PubMedGoogle Scholar
• Espinal MA, Kim SJ, Suarez PG et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA283, 2537–2545 (2000).
   PubMed Web of Science ®Google Scholar
• Sotgiu G, Ferrara G, Matteelli A et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur. Respir. J.33, 871–881 (2009).
   PubMed Web of Science ®Google Scholar
• Migliori GB, Ortmann J, Girardi E et al.; SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg. Infect. Dis.5, 780–782 (2007).
   Google Scholar
• Migliori GB, Besozzi G, Girardi E et al.; SMIRA/TBNET Study Group. Clinical and operational value of the XDR-TB definition. Eur. Respir. J.30, 623–626 (2007).
   PubMed Web of Science ®Google Scholar
• Sotgiu G, Sorete-Arbore A, Kliimann K et al. Social determinants of MDR-TB in Europe: a multicentre TBNET study. Eur. Respir. J.34(S53), 4446 (2009).
   Google Scholar
• Wells CD, Peter Cegielski J, Nelson LJ et al. HIV infection and multidrug-resistant tuberculosis– the perfect storm. J. Infect. Dis.196, S86–S107 (2007).
   PubMed Web of Science ®Google Scholar
• Drobniewski FA, Hoffner S, Rusch-Gerdes S, Skenders G. Recommended standards for modern tuberculosis laboratory services in Europe. Eur. Respir. J.28, 903–909 (2006).
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Framework Action Plan to fight tuberculosis in the European Union. Stockholm, Sweden, February 2008.
   Google Scholar
• Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International Standards for Tuberculosis Care. Lancet Infect. Dis.6, 710–725 (2006).
   PubMed Web of Science ®Google Scholar